We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tissue-Integrated Sensitive Glucose Nanosenor to Revolutionize Diabetes Management

By HospiMedica International staff writers
Posted on 03 Jan 2024

The key task of monitoring blood glucose levels is typically accomplished through the use of enzyme glucose oxidase (GOx)-based electrochemical sensors. More...

Despite their effectiveness, these sensors produce the toxic byproduct hydrogen peroxide and also require cumbersome electrical components and batteries, complicating the development of continuous, implantable monitoring devices. An alternative approach involves single-wall carbon nanotubes (SWCNTs), which, when excited by light, emit near-infrared fluorescence that penetrates tissue and can be captured by non-invasive bioimaging techniques. However, integrating GOx with SWCNTs to create nanosensors is challenging as the typical method for attaching molecules to SWCNTs, sonication, deactivates the GOx molecules.

To address these challenges, scientists at the University of California, Berkeley (Berkeley, CA, USA) have innovated a battery-free fluorescent nanosensor that combines SWCNTs with an inactive form of GOx. This groundbreaking design allows for the continuous, reversible, and non-invasive bioimaging of glucose levels in body fluids and tissues. This development overturns the prevailing belief that GOx-based sensors require active GOx for effective glucose sensing. Through sonication, the team produced GOx-loaded SWCNT sensors capable of accurately and selectively detecting glucose in various mediums like serum, plasma, and even within mouse brain tissue.

According to the researchers, inactive GOx enzyme can still bind to glucose without converting it, and binding alone proved sufficient to modulate the fluorescence signal. In order to be completely independent of GOx activity, the researchers also created a GOx enzyme that even lacked the reactive group for glucose conversion. The resulting apo-GOx-SWCNT sensor was able to detect glucose in body fluids and mouse brain slices as reliably as the original conjugate of SWCNT and natural GOx. The researchers suggest that the use of inactive GOx molecules offers key advantages. For instance, it is possible to simplify the manufacturing process of the GOx-SWCNT nanosensors by utilizing sonication as an effective preparation step. Additionally, since the analyte is not consumed by the enzyme reaction, there are no toxic byproducts produced, and the measurements are intrinsically reversible, enabling the non-invasive continuous monitoring of glucose in tissue fluids.

Related Links:
University of California, Berkeley


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.